Best Clinical Documentation Specialist Podcasts (2024)

1
Improving Clinical Documentation Efficiency with AI 2:20

24m ago2:20

2:20

Dr. Irfan Sheikh explores a newly released NeuroByte episode, providing an insightful overview of how AI technologies, including ambient intelligence, can streamline documentation processes and enhance the efficiency of clinical practices. Show references: https://learning.aan.com/courses/74256By American Academy of Neurology

1
Monoclonal Antibody to PACAP for Migraine Prevention - Part 2 4:00

1h ago4:00

4:00

In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577By American Academy of Neurology

1
Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene 3:09

9h ago3:09

3:09

Dr. Rae Bacharach discusses the Neurology Today article, "Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene?" by Gina Shaw, available in the September 5th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/0905…

1
Monoclonal Antibody to PACAP for Migraine Prevention - Part 1 4:54

5h ago4:54

4:54

In the first installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina explore the biology of PACAP, its significance in relation to migraines, and its potential as a novel therapeutic approach. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577By American Academy of Neurology

1
Association of Extent of TSS With Cerebral Glymphatic Clearance in Patients With IIH 2:07

1d ago2:07

2:07

Dr. Amy Gelfand and Dr. Matthew Bender discuss the possible association between glymphatic outflow and extent of TSS in patients with IIH. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209529

1
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome 1:55

2d ago1:55

1:55

Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org. Show reference: https://www.neurology.org/doi/…

1
Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses 2:44

3d ago2:44

2:44

Dr. Rae Bacharach discusses the Neurology Today article, "Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses" by Susan FitzGerald, available in the September 5th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09050/large_study_finds_covid_vacc…

1
Spinal Muscular Atrophy Update in Best Practices - Part 3 1:33

4d ago1:33

1:33

In the third episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the critical objective of advancing the quality of life for individuals with SMA in the coming years. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310By American Academy of Neurology

1
Specialist Physiotherapy for Functional Motor Disorder 1:42

7d ago1:42

1:42

Dr. David Perez and Dr. Glenn Nielsen discuss the effectiveness of physiotherapy in treating functional motor disorder and to determine the best approach for physiotherapy treatment. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00135-2/fulltextBy American Academy of Neurology

1
Spinal Muscular Atrophy Update in Best Practices - Part 2 1:59

14d ago1:59

1:59

In the second episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the currently available treatments for spinal muscular atrophy. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310By American Academy of Neurology

1
Spinal Muscular Atrophy Update in Best Practice - Part 1 3:07

9d ago3:07

3:07

In the first episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the most common types of spinal muscular atrophy. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310By American Academy of Neurology

1
Blood Biomarkers to Detect Alzheimer Disease - Part 2 1:47

10d ago1:47

1:47

In part two of this series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss how this new blood test can enhance the accuracy of diagnosing Alzheimer’s disease in patients with cognitive symptoms. Show reference: https://jamanetwork.com/journals/jama/fullarticle/2821669By American Academy of Neurology

1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 2 1:38

17d ago1:38

1:38

In the second part of this two-part series, Dr. Jeff Ratliff and Dr. Calum Hamilton discuss the clinical criteria that listeners should look out for, indicating a subtype of mild cognitive impairment known as DLB, which could potentially progress into a full dementia with Lewy body phenotype. Show reference: https://www.neurology.org/doi/10.1212/WN…

1
Blood Biomarkers to Detect Alzheimer Disease - Part 1 1:41

14d ago1:41

1:41

In part one of this two-part series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss the top-line findings from the study exploring the diagnostic performance of blood biomarkers for Alzheimer disease in clinical cohorts. Show reference: https://jamanetwork.com/journals/jama/fullarticle/2821669By American Academy of Neurology

1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 1 1:12

21d ago1:12

1:12

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Calium discuss the risk of developing dementia among patients with MCI at three or five-year time points. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209499By American Academy of Neurology

1
New Treatment Option for Parkinson Disease 2:33

16d ago2:33

2:33

Dr. Jeff Ratliff talks about the FDA approval of Crexont for the treatment of Parkinson disease. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496By American Academy of Neurology

1
Chronic Adaptive Deep Brain Stimulation Versus Conventional Stimulation in Parkinson Disease 3:07

23d ago3:07

3:07

Dr. Jeff Ratliff discusses an exciting study in the world of deep brain stimulation for Parkinson disease. Show reference: https://www.nature.com/articles/s41591-024-03196-zBy American Academy of Neurology

51
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse 2:03

23d ago2:03

2:03

Dr. Tesha Monteith talks about the efficacy of atogepant for the preventive treatment of chronic migraine in participants with and without acute medication overuse. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209584By American Academy of Neurology

51
Neuropsychological Profiles of Deployment-Related mTBI 3:05

26d ago3:05

3:05

Dr. Stacey Clardy and Dr. Nicola de Souza discuss how to improve care in the clinic for these veterans and military service members. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209417By American Academy of Neurology

1
Long-Term Dementia Risk in Parkinson Disease - Part 1 2:37

28d ago2:37

2:37

In the first installment of this two-part series, Dr. Jeff Ratliff and Dr. Daniel Weintraub discuss the risks associated with the development of dementia in patients diagnosed with Parkinson disease. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209699By American Academy of Neurology

1
Interpreting DAT Imaging Results in the Clinical Context - Part 2 2:01

29d ago2:01

2:01

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss why clinicians should be cautious when relying too much on dopaminergic imaging. Show reference: https://doi.org/10.1212/WNL.0000000000209453By American Academy of Neurology

1
Understanding Long COVID - Part 2 1:55

30d ago1:55

1:55

In part two of this two-part series, Dr. Tesha Monteith discusses the key features of long COVID. Show reference: https://doi.org/10.17226/27768By American Academy of Neurology

1
Understanding Long COVID - Part 1 1:30

1M ago1:30

1:30

In part one of this two-part series, Dr. Tesha Monteith discusses the 2024 National Academies of Sciences, Engineering, and Medicine formal definition of long COVID. Show reference: https://doi.org/10.17226/27768By American Academy of Neurology

1
Interpreting DAT Imaging Results in the Clinical Context 1:37

1M ago1:37

1:37

Dr. Jeff Ratliff and Dr. Eduardo De Pablo-Fernández discuss the strengths of dopamine transporter imaging or DAT imaging in diagnosing patients with Parkinsonian disorders. Show references: https://doi.org/10.1212/WNL.0000000000209453By American Academy of Neurology

1
New Data and New Controversies on Cardiac Monitoring and Anticoagulation - Part 1 2:33

1M ago2:33

2:33

Dr. Dan Ackerman and Dr. Luciano A. Sposato discuss the topic of embolic stroke of undetermined sources and the controversies surrounding cardiac monitoring and anticoagulation. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209535By American Academy of Neurology

Podcasts Worth a Listen

Clinical Documentation Specialist Podcasts

Podcasts Worth a Listen

1
Neurology Minute

American Academy of Neurology

1
Improving Clinical Documentation Efficiency with AI 2:20

1
Monoclonal Antibody to PACAP for Migraine Prevention - Part 2 4:00

1
Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene 3:09

1
Monoclonal Antibody to PACAP for Migraine Prevention - Part 1 4:54

1
Association of Extent of TSS With Cerebral Glymphatic Clearance in Patients With IIH 2:07

1
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome 1:55

1
Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses 2:44

1
Spinal Muscular Atrophy Update in Best Practices - Part 3 1:33

1
Specialist Physiotherapy for Functional Motor Disorder 1:42

1
Spinal Muscular Atrophy Update in Best Practices - Part 2 1:59

1
Spinal Muscular Atrophy Update in Best Practice - Part 1 3:07

1
Blood Biomarkers to Detect Alzheimer Disease - Part 2 1:47

1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 2 1:38

1
Blood Biomarkers to Detect Alzheimer Disease - Part 1 1:41

1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 1 1:12

1
New Treatment Option for Parkinson Disease 2:33

1
Chronic Adaptive Deep Brain Stimulation Versus Conventional Stimulation in Parkinson Disease 3:07

51
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse 2:03

51
Neuropsychological Profiles of Deployment-Related mTBI 3:05

1
Long-Term Dementia Risk in Parkinson Disease - Part 1 2:37

1
Interpreting DAT Imaging Results in the Clinical Context - Part 2 2:01

1
Understanding Long COVID - Part 2 1:55

1
Understanding Long COVID - Part 1 1:30

1
Interpreting DAT Imaging Results in the Clinical Context 1:37

1
New Data and New Controversies on Cardiac Monitoring and Anticoagulation - Part 1 2:33

Quick Reference Guide